Earn 0 reward points

We’re sorry we’re out of stock, but we can let you know as soon as this product becomes available again.

Enter your details below and we’ll email you once this item is back in stock.

Your NameYour Email Address


ACP-105 is a SARM, or selective androgen receptor modulators, that was created to help individuals with degenerative bone disorders. Due to the nature of the supplement and its potential for increased muscle growth, it is also regularly used by individuals interested in muscle and bodybuilding. Overall, the drug helps individuals to build endurance, gain lean muscle, and increase strength.

Qty: 30 tablets


Supplied for Research Purposes Only

This information and product is provided for research purposes only. We do not provide any advice on the usage of these products as UK Law prevents this. Customers should check the legality of this product in their own country prior to purchase.

Benefits and uses:

Athletes use ACP 105 for muscle and strength gains without the negative health impact of stronger SARMS such as RAD 140.

Patients suffering from degenerative bone problems may benefit from treatment with ACP-105, which was developed specifically for this purpose. It was utilised in the treatment of conditions such as osteoporosis and arthritis. It was conceived with the intention of providing a less harmful substitute for anabolic androgen steroids as well as prohormones. This causes it to attach to the androgen receptors that are present in the muscle tissue as well as the bone tissue. It is equivalent to testosterone in terms of its strong anabolic effects; nevertheless, it is significantly safer than testosterone. Surprisingly, there are no severe negative side effects associated with its use, making it a risk-free method for building lean muscle mass, strength, and endurance.


At this point in time, it is not possible to talk with complete and utter conviction about how potent ACP-105 is. The ratio of its androgenic effects to its anabolic effects is said to be 1:3. Studies and research on animals have shown that its activity is similar to that of testosterone; nevertheless, there is not enough information available to prove how powerful it is. Because ACP is only a partial agonist, the suppression it exerts is extremely mild in comparison to that of other SARMs such as RAD-140.

This does not negate the requirement for post-cycle therapy in any way (PCT). After using ACP-105 for some time, a visible suppression of testosterone will occur, which causes a person to experience a heightened susceptibility to fatigue and nausea as a side effect. Maintaining ready access to a PCT is strongly encouraged at all times. We carry PCT here:

However, there are a plethora of advantages that accompany it. The following is a list of some of these:

By utilising the fat and then burning it off, it assists in the reduction of aberrant fat that may be present in the body.

It promotes the formation of muscle tissue while halting the breakdown of existing muscle, a quality that enables it to be effective in the treatment of bone problems such as osteoporosis.

It helps a person recuperate from tiredness and injuries more quickly.

It does this by elevating levels of the androgenic receptor in the region of the hippocampus, which in turn improves cognitive abilities and memory.

Because it gives the body the energy it needs and the strength it needs to endure, it prevents you from becoming fatigued as quickly.

It has shown promise as a treatment for patients suffering from cachexia, prostate cancer, and breast cancer.

It is effective in a pretty short amount of time and produces results.

It is a much less dangerous alternative to androgenic anabolic steroids.

How does ACP-105 work?

ACP achieves its effects by functioning in a manner analogous to that of testosterone. Because it forms specific bonds with individual androgen receptors and exerts a distinct effect on each of those receptors, it is able to carry out its intended function without causing any harm to the body's vital organs. It does this by lowering levels of high-density lipoproteins and increasing levels of lean body mass, both of which allow a person to gain muscle without increasing their body fat percentage. If aromatization does not take place, there will be no increase in oestrogen levels, and therefore no retention of water.

The Adverse Consequences of ACP

The following are some of the adverse reactions that have been linked to the usage of ACP 105: – A little headache, which typically appears when you first begin taking the product but goes away as you continue to make use of it: Constant headaches are a potential side effect of taking a dosage that is higher than what is recommended.

 A suppression of testosterone levels after using the product for around six to eight weeks. This can result in feelings of weariness as well as nausea. Taking a PCT supplement can help fix this issue.

It is important to note that none of these adverse effects are irreversible and that they can be easily treated.

What dosage should I take?

According to the findings of experiments performed on clinical rats, the recommended dosage is one mg per 10kg of body weight once daily for approximately eight weeks. It is also recommended that the medication be consumed after a meal and around thirty minutes before beginning an exercise routine.


The vast majority of people who have tried ACP 105 have said that it has provided them with satisfactory benefits, including enhanced strength, improved endurance, and muscular growth without leading to obesity. should be reasonably priced soma It is a drug that you can trust to provide without causing you any harm in any manner, as it has side effects that are both mild and reversible.


Schlienger N, Lund BW, Pawlas J, Badalassi F, Bertozzi F, Lewinsky R, et al. (November 2009). "Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators". Journal of Medicinal Chemistry. 52 (22): 7186–7191. doi:10.1021/jm901149c. PMID 19856921.

 Dayger C, Villasana L, Pfankuch T, Davis M, Raber J (March 2011). "Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice". Brain Research. 1381: 134–140. doi:10.1016/j.brainres.2010.12.088. PMC 3048897. PMID 21219889.

 George S, Petit GH, Gouras GK, Brundin P, Olsson R (December 2013). "Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease". ACS Chemical Neuroscience. 4 (12): 1537–1548. doi:10.1021/cn400133s. PMC 3867967. PMID 24020966.

 Cutler C, Viljanto M, Taylor P, Hincks P, Biddle S, Van Eenoo P (October 2021). "Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes". Drug Testing and Analysis. 14 (2): 349–370. doi:10.1002/dta.3189. PMID 34714606. S2CID 240152623.

Be the first to review this product.

Leave a review